Gene Expression Assay Classifies Diffuse Large B-Cell Lymphoma

Share this content:
Gene Expression Assay Classifies Diffuse Large B-Cell Lymphoma
Gene Expression Assay Classifies Diffuse Large B-Cell Lymphoma

THURSDAY, Oct. 19, 2017 (HealthDay News) -- A novel gene expression profiling diffuse large B-cell lymphoma (DLBCL) classifier, which evaluates the expression of 21 markers, is effective for classifying samples, according to a study published online Oct. 17 in the Journal of Molecular Diagnostics.

Victor Bobée, Pharm.D., from the University of Normandie in France, and colleagues developed a novel gene expression profiling DLBCL classifier based on reverse transcriptase multiplex ligation-dependent probe amplification, which simultaneously assesses the expression of 21 markers. The assay differentiates primary mediastinal B-cell lymphoma, activated B-cell-like, germinal center B-cell-like, and Epstein-Barr virus-positive DLBCLs.

The assay was trained using 70 paraffin-embedded biopsies and validated using more than 160 samples. The researchers found that reverse transcriptase multiplex ligation-dependent probe amplification classified 85 percent of the samples into the expected subtype compared with a reference classification established from Affymetrix U133+2 data; this compared favorably with current diagnostic methods. Even in archival paraffin-embedded tissues, this assay proved to be highly efficient for detecting the MYD88 L265P mutation.

"This reliable, rapid, and cost-effective method uses common instruments and reagents and could thus easily be implemented into routine diagnosis workflows, to improve the management of these aggressive tumors," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Actigraphy May Overestimate Sleep in ICU Setting

Actigraphy May Overestimate Sleep in ICU Setting

Wide ranges of sleep quality and quantity with use of actigraphy among critically ill patients in ICU

Mortality for Unintentional Drug Poisonings Up Since 1979

Mortality for Unintentional Drug Poisonings Up Since 1979

Trajectory of overall mortality rate smooth; no exponential trajectories in rates for individual drugs

Most Breast Cancer Diagnoses Given Over the Phone

Most Breast Cancer Diagnoses Given Over the Phone

This represents a reversal, with in-person diagnoses more common before 2006

is free, fast, and customized just for you!




Already a member?

Sign In Now »